Q2 FY2026 · ended Jun 30, 2026 · Revenue $418,264, -15.7% YoY · Filed Aug 14, 2026
Vycor Medical, Inc. (VYCO) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $418,264 and a net loss of $22,288. As of Jun 30, 2026 it held $158,907 in cash and investments and $26,700 in total debt.
Revenue
$418,264
-15.7% vs year-ago quarter
Net income
$-22,288
-193.3% vs year-ago quarter
Operating cash flow
$-4,843
-110.4% vs year-ago quarter
Free cash flow
$37,627
+198.3% vs year-ago quarter
EPS
$0.00
Dividend per share
None
Shares outstanding
33.37M
+0.0% vs year-ago quarter
Net cash
$132,207
Q2 FY2026
Operating margin
2.7%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- VYCO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boca Raton,, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1424768
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $418,264 | $458,540 | $416,877 | $513,792 | $496,353 |
| Operating income | $6,851 | $45,808 | -$36,525 | $32,085 | $51,146 |
| Net income | -$22,288 | $20,108 | -$62,686 | $4,936 | $23,887 |
| Diluted EPS | $0.00 | $0.00 | -$0.00 | $0.00 | $0.00 |
| Operating cash flow | -$4,843 | $99,422 | $39,232 | -$72,427 | $46,633 |
| Free cash flow | — | — | $37,627 | -$76,046 | $43,015 |
| Total assets | $813,174 | $854,071 | $830,420 | $941,195 | $878,946 |
| Total liabilities | $5.1M | $5.1M | $4.9M | $5.0M | $4.7M |
| Stockholders' equity | -$4.3M | -$4.2M | -$4.1M | -$4.0M | -$3.9M |
| Cash and investments | $158,907 | $173,634 | $86,982 | $64,230 | $99,700 |
| Total debt | $26,700 | $39,540 | $52,221 | $64,745 | $76,857 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
All 462 Vycor Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.